Targetable cell signaling pathways in cancer
Focusing on DNA damage response in primary central nervous system lymphoma (PCNSL) and the AKT and MAPK/ERK signaling pathway in non-small cell lung cancer (NSCLC)
Promotie:Mw. H. (Haiying) MoWanneer:03 september 2026 Aanvang:09:00Promotor:prof. dr. T. van MeertenCopromotor:A. VisserWaar:Academiegebouw RUGFaculteit:Medische Wetenschappen / UMCG